CML TKI Register for original and generic TKIs
We have compiled an inofficial directory including all CML Tyrosine Kinase Inhibitors, that are - to our knowledge - available to date.
See our inofficial CML TKI Register here.
It provides information on the product name, compound name, registration status of all TKIs available on the international markets, the name of the respective manufacturer and / or Marketing Authorization Holder (MAH) and the specific indication of each drug. If available, it also provides links to publicly available documents (summaries of the European Public Assessment Report (EPAR), bioequivalence studies and manufacturer´s instructions).
All information is based on data provided by EMA (European Medicines Agency), the FDA (US Food and Drug Administration), on informal community submissions, and on data collected in our recent CML Advocates Network Survey on generics.
The register only covers Tyrosine Kinase Inhibitors so far, but might be extended to other types of CML drugs in the future.
This is a community-driven initiative - please contribute and share!
Therefore, your contribution with additional or corrected data is essential! We look forward to receiving your updates on approval status, availability of new and known generics in your country, and on products newly approved by your local competent authorities.
This is non-commercial!
This is a purely patient-driven, non-commercial initiative. It has no interest to promote, or assess, any of the drugs. The only intent is to increase transparency in a confusing environment.